Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer

References

• Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731–40
   PubMed Web of Science ®Google Scholar
• Bosset JF, Calais G, Daban A, Berger C, Radosevic-Jelic L, Maingon P, et al. Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: Assessment of acute toxicity and treatment compliance, report of the 22 921 randomized trial conducted by the EORTC radiotherapy group. Eur J Cancer 2004; 40: 219–24
   PubMed Web of Science ®Google Scholar
• Brændengen M, Tveit KM, Berglund Å, Birkemeyer E, Frykholm G, Påhlman L, et al. A randomized phase III study (LARCS) comparing preoperative radiotherapy alone versus chemoradiotherapy in non-resectable rectal cancer. ECCO 13-the European Cancer Conference 2005;[Abstract #612].
   Google Scholar
• De Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18: 2938–47
   PubMed Web of Science ®Google Scholar
• Giacchetti S, Perpoint B, Zidani R, Le Bail N, Faggiuolo R, Focan P, et al. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 2000; 18: 136–47
   PubMed Web of Science ®Google Scholar
• Källström J, Kjellén E, Johnsson A. In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line. Acta Oncol 2005; 44: 687–93
   PubMedGoogle Scholar
• Rödel C, Grabenbauer GG, Papadopoulos T, Hohenberger W, Schmoll H-J, Sauer R. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 2003; 20: 3098–104
   Google Scholar
• Machiels JP, Duck L, Honhon B, Coster B, Coche J-C, Scalliet P, et al. Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: The radioxcape study. Ann Oncol 2005; 16: 1898–905
   PubMed Web of Science ®Google Scholar
• Grann A, Feng C, Wong D, Saltz L, Paty PP, Guillem JG, et al. Preoperative combined modality therapy for clinically resectable UT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2001; 40: 515–22
   Google Scholar
• Hyams DM, Mamounas EP, Petrelli N, Rockette H, Jones J, Wieand S, et al. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum. A progress report of the National Surgical Adjuvant Breast an Bowel Project Protocol R-03. Dis Colon Rectum 1997; 40: 131–9
   PubMed Web of Science ®Google Scholar
• Minsky BD, Conti JA, Huang Y, Knopf K. Relationship of acute gastrointestinal toxicity and the volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer. J Clin Oncol 1995; 13: 1409–16
   PubMed Web of Science ®Google Scholar
• Baglan KL, Frazier RC, Yan D, Huang RR, Martinez AA, Robertson JM. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 2002; 52: 176–83
   PubMed Web of Science ®Google Scholar
• Tho LM, Glegg M, Paterson J, Yap C, MacLeod A, McCabe M, et al. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: Investigating dose-volume relationships and role for inverse planning. Int J Radiat Oncol Biol Phys 2006; 66: 505–13
   PubMed Web of Science ®Google Scholar
• Sørbye H, Glimelius B, Berglund Å, Fokstuen T, Tveit KM, Brændegen M, et al. Multicenter phase II study of Nordic fluorouracil and folinic acid bolus schedule combined with oxaliplatin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 2004; 22: 31–8
   PubMed Web of Science ®Google Scholar
• International Commission of Radiation Units and Measurements. ICRU report 50: Prescribing, recording and reporting photon beam therapy. Bethesda: International Commission of Radiation Units and Measurements; 1993.
   Google Scholar
• International Commission on Radiation Units and Measurements. ICRU report 62: Prescribing, recording, and reporting photon beam therapy (supplement to ICRU report 50). Bethesda: ICRU; 1999.
   Google Scholar
• Trotti A, Byhardt R, Stetz J, Gwede C, Corn B, Fu K, et al. Common toxicity criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy. Int J Radiat Oncol Phys 2000; 47: 13–47
   PubMed Web of Science ®Google Scholar
• Lyman JT. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl 1985; 8: S13–S19
   PubMedGoogle Scholar
• Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method. Int J Radiat Oncol Biol Phys 1989; 16: 1623–30
   PubMed Web of Science ®Google Scholar
• Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991; 21: 123–35
   PubMed Web of Science ®Google Scholar
• Källman P, Agren A, Brahme A. Tumour and normal tissue responses to fractionated non-uniform dose delivery. Int J Radiat Biol 1992; 62: 249–62
   PubMed Web of Science ®Google Scholar
• Niemierko A. A generalized concept of Equivalent Uniform Dose (EUD). Med Phys 1999; 26: 1101
   Google Scholar
• Muren LP, Jebsen N, Gustafsson A, Dahl O. Can dose-response models predict reliable normal tissue complication probabilities in radical radiotherapy of urinary bladder cancer? The impact of alternative radiation tolerance models and parameters. Int J Radiat Oncol Biol Phys 2001; 50: 627–37
   PubMed Web of Science ®Google Scholar
• Muren LP, Hafslund R, Gustafsson A, Smaaland R, Dahl O. Partially wedged beams improve radiotherapy treatment of urinary bladder cancer. Radiother Oncol 2001; 59: 21–30
   PubMedGoogle Scholar
• Touboul E, Balosso J, Schlienger M, Laugier A. Radiation injury of the small intestine. Radiobiological, radiopathological aspects; risk factors and prevention. Ann Chir 1996; 50: 58–71
   PubMedGoogle Scholar
• Koelbl O, Richter S, Flentje M. Influence of patient positioning on dose-volume histogram and normal tissue complication probability for small bowel and bladder in patients receiving pelvic irradiation: A prospective study using a 3D planning system and a radiobiological model. Int J Radiat Oncol Biol Phys 1999; 45: 1193–8
   PubMed Web of Science ®Google Scholar
• Shanahan TG, Mehta MP, Bertelrud KL, Buchler DA, Frank LE, Gehring MA, et al. Minimization of small bowel volume within treatment fields utilizing customized “belly boards”. Int J Radiat Oncol Biol Phys 1990; 19: 469–76
   PubMed Web of Science ®Google Scholar
• Huh SJ, Lim DH, Ahn YC, Kim DY, Kim MK, Wu HG, et al. Effect of customized small bowel displacement system in pelvic irradiation. Int J Radiat Oncol Biol Phys 1988; 40: 623–7
   Google Scholar